Short Note about the Company:
Shalby Limited (Incorporated in 2004 ) is Ahmedabad based leading multi-specialty chain of hospitals in India. The Company has 8 fully operational hospitals with an aggregate operational bed count of 781 beds. It also provides outpatient consultative healthcare services through 3 hospitals and 68 Outpatient Clinics. It has 8 shared-surgery-centers within third party hospitals.The company operate across five states and Outpatient Clinics operate across 53 cities in 16 states in India. Company also has six Outpatient Clinics and one Shalby Arthroplasty Centre of Excellence (SACE) in Africa, and two SACE in the UAE.
Shalby hospitals are well known for its orthopaedic services & it had 15% market share of all joint replacement surgeries conducted by private corporate hospitals in India during 2016. The company also provides advanced levels of care across neurology, cardiac care, critical care, oncology, and nephrology.Since March 2007, Shalby hospitals have conducted an aggregate of 84,579 surgeries, and provided healthcare services to an aggregate of 923,441 patients, consisting 121,576 inpatients and 801,865 outpatients.
Professional Team :
Shalby hospital is led by Dr Vikram Shah, an orthopaedic surgeon with more than 25 years of professional experience. Dr Vikram Shah is one of the promoters of the company.
As of December 31, 2016, Shalby hospital employed 1,599 employees and engaged 267 professional consultants, consisting 242 doctors who are full-time consultants and 25 doctors who are part-time consultants. Hospital’s staff strength also comprises 458 nurses and 1,141 paramedical, corporate and support staff and pharmacists.
The promoters :
Dr Vikram Shah, Dr Darshini Shah, Shanay Shah, Shah Family Trust, and Zodiac Mediquip Limited. Dr Vikram Shah, Dr Darshini Shah, Shanay Shah, Shah Vikram Indrajit HUF and Shah Indrajit Chimanlal HUF are the promoters of Zodiac Mediquip Limited
»» Issue Open: Dec 5, 2017 - Dec 7, 2017
»» Issue Type: Book Built Issue IPO
»» Issue Size:
› Fresh Issue of [.] Equity Shares of Rs 10 aggregating up to Rs 480.00 Cr
› Offer for Sale of 1,000,000 Equity Shares of Rs 10 aggregating up to Rs [.] Cr
»» Face Value: Rs 10 Per Equity Share
»» Issue Price: Rs 245 - Rs 248 Per Equity Share
»» Market Lot: 60 Shares
»» Minimum Order Quantity: 60 Shares
»» Listing At: BSE, NSE
Tentative timetable in respect of the Offer:
Bid/Offer Opens On: December 05, 2017
Bid/Offer Closes On: December 07, 2017
Finalisation of Basis of Allotment: On or about December 12, 2017
Initiation of refunds: On or about December 13, 2017
Credit of Equity Shares to demat accounts: On or about December 14, 2017
Commencement of trading of the Equity Shares on the Stock Exchanges: On or about December 15, 2017
Objects of the Issue:
The Offer comprises of the Fresh Issue and the Offer for Sale.
Company proposes to utilise the Net Proceeds from the Fresh Issue towards the following objects:
1. Repayment or prepayment in full, or in part of certain loans availed by the Company;
2. Purchase of medical equipment for existing, recently set up, and upcoming hospitals;
3. Purchase of interiors, furniture, and allied infrastructure for upcoming hospitals; and
4. General corporate purposes.
Company will not receive any proceeds from the Offer for Sale.
My view :
+Ve
Sector is good
Good management
Profits are rising year on year
New hospitals are being constructed
-ve
The stock is not showing much fancy in grey market
It is a bit overvalued
GUJARAT ELECTIONS (overall market sentiments)
Conclusion : Avoid
( Long term investors may apply as financially the company is strong and growing)
Disclaimer : i am not a sebi registered analyst.
